About CQDM
Structure and Governance
Executive Committee
The Executive Committee currently consists of David Brener, Leon Gosselin, Don Olds, all of whom are independent directors, and Max Fehlmann, who is a director and officer of CQDM.
The Executive Committee exercises, under the management of the directors, all the powers of the directors with regard to the management and control of the business of the Corporation. The Executive Committee consults with, and assists, the officers and the representatives in all business regarding the Corporation and its management.
Chairman
Léon Gosselin
Co-founder of Axcan Pharma
Members
Richard Fajzel
General Manager, Oncology Business Unit, Pfizer Canada inc.
Max Fehlmann
President and Chief Executive Officer
Neil Maresky
Vice-President, Medical Affairs, AstraZeneca
Canada Inc.
Donald Olds
President and CEO, Presagia Corporation